Insider · CIK 0001748392
Timothy Williams
Files at GERN (GERON CORP), VNDA (Vanda Pharmaceuticals Inc.). First filing Mar 4, 2026, latest Mar 4, 2026.
Timothy Williams files SEC Form 4 as officer at VNDA (Vanda Pharmaceuticals Inc.), and also at GERN (GERON CORP). Since Mar 4, 2026, Timothy Williams has reported 0 open-market buys worth $0 and 1 open-market sell worth $351k, the latest filed on Mar 4, 2026.
A track record needs three past buys with six months of prices behind them; Timothy Williams has 0, so none is measured yet.
The newest scored trade: sold $351k of VNDA on Mar 2, 2026, filed Mar 4, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $351k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VNDA: Vanda Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Vanda Pharmaceuticals Inc. | $351k 42,434 shares | -10% | +108% from low-8% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | GERN GERON CORP | AGrant or award Stock Option (Right to Buy)derivative | +2,500,000 | $0.00 | $0 | 2,500,000 | Apr 14, 2026 |
| Mar 2, 2026 | VNDA Vanda Pharmaceuticals Inc. | SOpen-market sale Common Stock | -42,434 | $8.27 | $351k | 377,450 | Mar 4, 2026 |
| Feb 18, 2026 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +125,000 | $0.00 | $0 | 419,884 | Feb 19, 2026 |
Questions about Timothy Williams
Answered from the filings on this page, as of the latest one.
Is Timothy Williams buying or selling?
In the last 12 months Timothy Williams reported 0 open-market buys worth $0 and 1 open-market sell worth $351k on SEC Form 4; the latest was sold $351k of VNDA on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Timothy Williams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy Williams has 0.
Where does Timothy Williams file Form 4?
Timothy Williams has filed Form 4 at VNDA (Vanda Pharmaceuticals Inc.) as SVP & General Counsel; GERN (GERON CORP) as EVP and Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.